Insider Transactions in Q1 2025 at Envista Holdings Corp (NVST)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2025
|
Mischa Reis SVP, Strategy & Bus. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
8,475
+15.17%
|
-
|
|
Feb 25
2025
|
Mark E Nance General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
18,155
+20.15%
|
-
|
|
Feb 25
2025
|
Mark E Nance General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,691
-6.42%
|
$73,820
$20.66 P/Share
|
|
Feb 25
2025
|
Eric D. Hammes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,735
+13.09%
|
-
|
|
Feb 25
2025
|
Robert Befidi President, Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
10,290
+17.37%
|
-
|
|
Feb 25
2025
|
Robert Befidi President, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,123
-2.82%
|
$22,460
$20.66 P/Share
|
|
Feb 25
2025
|
Stefan Nilsson President, Nobel Biocare |
BUY
Grant, award, or other acquisition
|
Direct |
10,290
+15.58%
|
-
|
|
Feb 25
2025
|
Veronica Acurio President, Orthodontics |
BUY
Grant, award, or other acquisition
|
Direct |
10,290
+15.58%
|
-
|
|
Feb 25
2025
|
Paul A Keel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,830
+13.71%
|
-
|
|
Feb 25
2025
|
Mischa Reis SVP, Strategy & Bus. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,813
-8.93%
|
$76,260
$20.66 P/Share
|
|
Feb 25
2025
|
Faez C Kaabi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,685
+16.23%
|
-
|
|
Feb 25
2025
|
Faez C Kaabi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,319
-9.68%
|
$86,380
$20.66 P/Share
|